Do three 10-minute bouts count as much as one 30-minute session?
For fitness in mostly sedentary adults, likely: 8 trials found no evidence of a VO2max difference (−0.50 mL/kg/min, CI −1.53 to 0.54). All at high risk of bias.
Main caveat: Risk of bias: all 19 trials high risk; selection unclear in 10, outcome assessors blinded in almost none, attrition ≥20% in many, no trial protocols.
Murphy and colleagues asked whether exercise accumulated in several short bouts across a day does as much for health as the same minutes done in one bout.
They searched six databases to 29 August 2018 for trials of at least 4 weeks in community-dwelling adults that compared a single daily bout with the same total daily and weekly duration, intensity and mode split into two to four bouts.
Nineteen trials (22 articles; 1080 randomised; median trial size 47) qualified; most prescribed brisk walking at moderate intensity, the commonest pattern being 3 × 10 min vs 1 × 30 min on 5 days a week, with a median prescribed dose of 110 min a week for a median of 12 weeks.
Accumulated and continuous exercise did not differ for any cardiorespiratory fitness outcome — VO2max (absolute and relative, after training and as change), exercise economy and test duration — nor for blood pressure, lipids other than LDL, glucose or insulin.
Compared with no-exercise controls, accumulated exercise raised VO2max (SMD 0.52; relative VO2max change +2.78 mL/kg/min). Body mass fell 0.92 kg more with accumulated than continuous exercise (5 trials), LDL cholesterol fell slightly more (2 trials), and continuous exercise lowered depression and anxiety scores more (2 trials).
Drop-out was higher with accumulated bouts (20% vs 16%). All trials were at high risk of bias. Our reading: for an untrained adult, the day's minutes of moderate exercise count whether done in one piece or in ≥10-min pieces; this is about building basic fitness, not about how a trained athlete should split a long ride.
Protocol
Registration and search: PROSPERO CRD42016044122; PubMed, EMBASE, CENTRAL, CINAHL, PEDro and SPORTDiscus from inception to June 2017, updated 29 August 2018; English only; two independent screeners and extractors.
Eligibility: free-living adults (≥18 y); training interventions of ≥4 weeks; accumulated arm = multiple bouts across a day; comparator = one daily bout at the same intensity, mode and total daily, weekly and intervention duration, and/or a no-exercise control; randomised, quasi-randomised or non-randomised comparative trials. Intermittent exercise within one session (e.g. HIIT) was excluded.
Trials: n = 1080 randomised in 19 trials (15 randomised parallel, 2 non-randomised parallel, 2 randomised crossover); 9 had a control arm. Median sample 47 (18-148); median group size 17 accumulated, 16 continuous, 15 control; only three trials had groups above 30.
Participants: mean age 40 (SD 9.6) y; nine trials women only, three men only; mean body mass 76 kg, mean BMI 28.0; baseline relative VO2max 30.6 ± 4.7 mL/kg/min (ten trials); one trial in women with fibromyalgia, the rest disease-free.
Interventions: median 12 weeks (4 to 72); median prescribed dose 1320 min in total, 110 min a week. Mode: walking 12, cycling 2, jogging 2, aerobics to music 1, mixed aerobic 1, resistance 1.Intensity "moderate" in all: 60-80% of maximal or reserve heart rate in 12 trials, 50% of VO2max (one cycling trial), 83% of estimated VO2max (one walking trial), RPE in two, "brisk" in others. Accumulated bouts: 10 min in 15 of 22 accumulated interventions (two to four a day, mostly three), 15 min in three; bouts typically 2-5 h apart.Continuous: most often 30 min on 5 days a week (150 min a week), range 60-210 min a week.
Risk of bias: Cochrane tool; all 19 trials at high risk; selective reporting unclear in all (no protocols); only one trial at low risk of selection bias.
Synthesis: inverse-variance random effects (RevMan 5.3); MD or SMD on change scores or post-intervention values; subgroups by weekly dose (<150, 150, >150 min).
Funding and interests: no funding for the review; the four authors declare no conflicts of interest.
Key Results
Accumulated minus continuous (Appendix S3; negative favours continuous for fitness):
| Outcome | Trials (participants) | Effect (95% CI) |
|---|---|---|
| VO2max after training, SMD | 9 (439) | −0.00 (−0.19 to 0.19) |
| Relative VO2max after training, mL/kg/min | 8 (379) | −0.50 (−1.53 to 0.54) |
| VO2max change, SMD | 6 (288) | −0.07 (−0.56 to 0.42) |
| Relative VO2max change, mL/kg/min | 4 (125) | +0.20 (−1.45 to 1.86) |
| Other cardiorespiratory fitness (economy etc.), SMD | 6 (285) | −0.09 (−0.42 to 0.25) |
| Exercise test duration | 4 (228) | −15.36 (−67.73 to 37.02) |
| Body mass change, kg | 5 (211) | −0.92 (−1.59 to −0.25), I² 0% |
| Body fat %, post-intervention and change combined | 8 (340) | −0.46 (−1.13 to 0.21) |
Accumulated minus no-exercise control:
| Outcome | Trials (participants) | Effect (95% CI) |
|---|---|---|
| VO2max after training, SMD | 4 (223) | 0.52 (0.24 to 0.81), I² 6% |
| Relative VO2max after training, mL/kg/min | 3 (197) | 2.32 (1.10 to 3.54), I² 4% |
| Relative VO2max change, mL/kg/min | 2 (110) | 2.78 (2.51 to 3.05), I² 0% |
| Diastolic blood pressure after training, mmHg | 4 (161) | −4.83 (−7.83 to −1.84) |
By weekly dose: no accumulated-vs-continuous fitness difference in any subgroup (<150, 150, >150 min a week); relative VO2max after training −0.30 (<150 min), −0.88 (150 min), −0.46 (>150 min), all CIs crossing zero.
Other outcomes: blood pressure, total and HDL cholesterol, triglycerides, glucose and insulin did not differ; LDL fell 0.39 mmol/L more with accumulated bouts (2 trials, 41 people); body fat % fell 0.87% more with accumulated bouts above 150 min a week (3 trials, 166); continuous exercise lowered POMS depression (SMD 0.93) and anxiety (0.68) more (2 trials, 41).
Adherence: drop-out 20% accumulated vs 16% continuous vs 14% control; in 12 trials completion was 78 ± 17% vs 83 ± 15%; continuous groups completed 3.88 percentage points more of their prescribed sessions, while accumulated groups did more objectively measured exercise (SMD 0.25, 6 trials).
Bouts under 10 min: only one intervention used bouts shorter than 10 min, so the review cannot speak to them.
Mechanisms
Measured: the same fitness change from split and continuous moderate exercise of equal daily minutes; slightly more body-mass loss with split bouts.
Authors' interpretation: for health outcomes, bout length does not matter once bouts are at least 10 min; two or three bouts may give a larger total post-exercise rise in metabolic rate than one, explaining the extra body-mass loss, and the LDL difference may follow from body mass.
Inference: in sedentary adults, the stimulus for VO2max from moderate exercise seems to follow the day's total minutes rather than the length of each bout. This sits with REF-1329 (weekly time, not frequency, at matched volume) and qualifies a per-session reading of REF-749's session-length curve, whose longer sessions also carried more weekly minutes (130 min a week for continuous training on average in that meta-analysis).
Practical Application
Do three 10-minute bouts count as much as one 30-minute session? For fitness in mostly sedentary adults, likely: 8 trials found no evidence of a VO2max difference (−0.50 mL/kg/min, CI −1.53 to 0.54). All at high risk of bias.
For a beginner or a returning athlete, short bouts are real training: bouts of 10 min or more at moderate intensity, added up over the day, raised VO2max by about 2.8 mL/kg/min over no exercise (2 trials) with no evidence of a difference from one continuous bout of the same total (−0.50 mL/kg/min, CI −1.53 to 0.54; A-, sedentary adults, mostly walking). A day with only 2-3 short windows still counts.
Splitting is not an adherence trick: raw drop-out was higher with accumulated bouts (20% vs 16%, not tested) and continuous groups completed 3.88 points more of their sessions, though accumulated groups did more objectively measured exercise (SMD 0.25); the authors suspect the fixed-schedule bouts were harder to keep than one opportunistic session.
For a trained rider, short split rides are easy time, not the long ride (inference): the trials were sedentary walkers at about 110 min a week. Not from this paper; the base's own practice (SYNTH-84): total weekly time and consistency come first; the long session is optional for events up to about 2 h, and for 2-5 h events spreading is fine in base, with a regular long ride in the last 8-10 weeks. Counting short split rides as easy minutes is our inference.
Below 10 min the evidence stops: one intervention only; the review cannot say whether bouts of a few minutes add up the same way.
Limitations
Risk of bias: all 19 trials high risk; selection unclear in 10, outcome assessors blinded in almost none, attrition ≥20% in many, no trial protocols; the authors call the estimates imprecise by GRADE.
Small and few: no group above 30 participants in 16 of 19 trials (median trial 47 randomised); the fitness pools hold 4-9 trials; accumulated vs control for VO2max change rests on 2 trials.
Who and what: sedentary, mostly female, mostly overweight adults walking at moderate intensity, median 110 min a week; no trained athletes, no long sessions (the longest continuous bouts were 40-47 min).
Outcome measures: seven trials measured VO2max maximally, seven by submaximal tests; heterogeneity is not reported in the text or appendix for the accumulated-vs-continuous fitness pools.
Pattern of splitting: two to four bouts a day, typically 2-5 h apart; the review cannot say which split is best, nor anything about bouts under 10 min.
Reporting: the Results text gives "−0.92%, four studies, 147 participants" as the accumulated-vs-continuous body-fat effect, but Appendix S3 shows that row (2.13) is accumulated vs control; the accumulated-vs-continuous row (1.18) is −0.46 (−1.13 to 0.21), 8 trials. The abstract calls standardised mean differences "MDs".Allocated arms (480 + 398 + 178 = 1056) fall 24 short of the 1080 randomised (our arithmetic; not explained).Table 2 lists DeBusk et al. as a 20-week trial; DeBusk's own abstract (PMID 2327335, checked 2026-10-28) says 8 weeks, and that trial (36 men aged about 51, 1 × 30 vs 3 × 10 min at 65-75% of peak heart rate) favoured the continuous bout for VO2max (between-group p < 0.05 in its abstract) — the pooled "no difference" averages over such disagreement.
English-language publications only.
Funding and interests: no funding; no conflicts declared.
How this entry was checked and changed
Why this level
19 trials, n = 1080 randomised, read from the full text and Electronic Supplementary Material Appendix S3 (open access, CC BY 4.0). Held below A because all 19 trials were rated at high risk of bias (no registered protocols, assessors mostly not blinded, attrition often ≥20%), in 16 of 19 no group exceeded 30 participants (the paper's "16 of 19 ... < 30 participants" can only mean per group, since the median trial randomised 47), the fitness pools hold 4-9 trials each, and heterogeneity is not reported for the accumulated-vs-continuous fitness pools
Full text (checked 2026-10-28)
A total of 19 studies involving 1080 participants met the inclusion criteria; PROSPERO 2016 CRD42016044122 (full text)
Relative maximal oxygen uptake after training, accumulated vs continuous: 8 trials, 379 participants, -0.50 [-1.53, 0.54] mL/kg/min; change: 4 trials, 125 participants, 0.20 [-1.45, 1.86], Appendix S3 (full text)
Accumulated vs control: VO2max SMD 0.52, 95% CI 0.24–0.81, I2 = 6%, four studies, 223 participants; relative VO2max change MD 2.78 ml/kg/min, 95% CI 2.51–3.05, two studies, 110 participants (full text)
Body mass change in favour of accumulated exercise: MD − 0.92 kg, 95% CI − 1.59 to − 0.25, I2 = 0%, five studies, 211 participants (full text)
The median total prescribed dose of exercise was 1320 min or 110 min per week; median intervention duration 12 weeks (full text)
Ten trials reported relative VO2max at baseline, mean ± SD 30.6 ± 4.7 ml/kg/min; average age 40 (9.6) years (full text)
The most common accumulated bout duration was 10 min (n = 15); bouts separated by typically 2–5 h (full text)
Drop-outs 20% in accumulated, 16% in continuous and 14% in control conditions; adherence 78 ± 17% vs. 83 ± 15% (full text)
Results text: body fat percentage −0.92%, 95% CI −1.78 to −0.07, four studies, 147 participants; Appendix S3 row 2.13 (accumulated vs control) -0.92 [-1.78, -0.07] and row 1.18 (accumulated vs continuous) -0.46 [-1.13, 0.21] (full text)
No sources of funding were used; the authors declare no conflicts of interest relevant to the content of this review (full text)